Clinical Trial Update: Blocking Tumor Necrosis Factor in Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating blockade of tumor necrosis factor in ankylosing spondylitis has completed. This update notes completion but does not provide resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Spondylitis, Ankylosing | Phase 2 | Status: COMPLETED